Alison Blain Selected Research

Limb-girdle muscular dystrophy type 2F

1/2013	Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy.
11/2010	Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison Blain Research Topics

Disease

6	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2016 - 11/2010
5	Cardiomyopathies (Cardiomyopathy) 02/2016 - 05/2009
4	Muscular Dystrophies (Muscular Dystrophy) 01/2013 - 11/2010
3	Fibrosis (Cirrhosis) 11/2010 - 05/2009
2	Limb-girdle muscular dystrophy type 2F 01/2013 - 11/2010
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2013
1	Body Weight (Weight, Body) 01/2013
1	Heart Failure 11/2010
1	Left Ventricular Dysfunction 05/2009

Drug/Important Bio-Agent (IBA)

3	CalciumIBA 01/2013 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 12/2016 - 11/2015
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 11/2015
2	Calcium Channels (Calcium Channel)IBA 01/2013 - 01/2011
2	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2013 - 11/2010
2	DystrophinIBA 01/2011 - 05/2009
2	SteroidsIBA 01/2010 - 05/2009
2	Prednisolone (Predate)FDA LinkGeneric 01/2010 - 05/2009
1	Antisense OligonucleotidesIBA 10/2015
1	ManganeseIBA 01/2013
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2011
1	AminoglycosidesIBA 01/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2011
1	Sarcoglycans (beta Sarcoglycan)IBA 11/2010
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2010
1	Messenger RNA (mRNA)IBA 11/2010
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2010
1	Mineralocorticoid Receptor AntagonistsIBA 01/2010
1	CytokinesIBA 05/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2009

Therapy/Procedure

4	Therapeutics 12/2016 - 11/2010
1	Investigational Therapies (Experimental Therapy) 11/2015
1	Aftercare (After-Treatment) 01/2013